Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaka Seino

Showing results (1-10 of 334) with videos related to

Pageof 34
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 2, 2004
[Physiopathology and etiological mechanism involving type 2 diabetes mellitus]Yutaka Seino
Expert Opinion on Pharmacotherapy|November 1, 2014
Luseogliflozin for the treatment of type 2 diabetesYutaka Seino
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 24, 2010
[New diagnostic criteria for diabetes in Japan]Yutaka Seino
The Journal of Clinical Endocrinology and Metabolism|April 9, 2011
Understanding the incretin effectYutaka Seino
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 28, 2009
[Present condition and future prospects in diagnosis of and therapy for diabetes mellitus]Yutaka Seino
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|February 9, 2025
Pathogenesis of type 2 diabetes in Japan and East Asian populations: Basic and clinical explorationsYutaka Seino, Yuji Yamazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2002
[The other gastrointestinal hormones in diabetes mellitus]Kazuhito Fukuda, Yutaka Seino
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2002
[Oxidative stress and development of type 1 diabetes]Rei Naitoh, Yutaka Seino
Expert Review of Endocrinology & Metabolism|February 10, 2019
Alogliptin for the treatment of Type 2 diabetesYutaka Seino, Daisuke Yabe
Expert Review of Endocrinology & Metabolism|February 10, 2019
Defining the role of GLP-1 receptor agonists for individualized treatment of Type 2 diabetesDaisuke Yabe, Yutaka Seino
Pageof 34

Showing results (1-10 of 334) with videos related to

Sort By:
Pageof 34
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 2, 2004
[Physiopathology and etiological mechanism involving type 2 diabetes mellitus]Yutaka Seino
Expert Opinion on Pharmacotherapy|November 1, 2014
Luseogliflozin for the treatment of type 2 diabetesYutaka Seino
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 24, 2010
[New diagnostic criteria for diabetes in Japan]Yutaka Seino
The Journal of Clinical Endocrinology and Metabolism|April 9, 2011
Understanding the incretin effectYutaka Seino
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 28, 2009
[Present condition and future prospects in diagnosis of and therapy for diabetes mellitus]Yutaka Seino
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|February 9, 2025
Pathogenesis of type 2 diabetes in Japan and East Asian populations: Basic and clinical explorationsYutaka Seino, Yuji Yamazaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2002
[The other gastrointestinal hormones in diabetes mellitus]Kazuhito Fukuda, Yutaka Seino
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2002
[Oxidative stress and development of type 1 diabetes]Rei Naitoh, Yutaka Seino
Expert Review of Endocrinology & Metabolism|February 10, 2019
Alogliptin for the treatment of Type 2 diabetesYutaka Seino, Daisuke Yabe
Expert Review of Endocrinology & Metabolism|February 10, 2019
Defining the role of GLP-1 receptor agonists for individualized treatment of Type 2 diabetesDaisuke Yabe, Yutaka Seino
Pageof 34